News
-
ANZCAP extends Foundation Program
Wednesday | Apr 10 2024THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has announced a one-time extension to its Foundation Program for Australian pharmacists, which was originally due to close this month.
-
RCPA unveils PGx guide
Wednesday | Apr 10 2024THE Royal College of Pathologists of Australasia (RCPA) has introduced a new guide to help health professionals understand when they should consider pharmacogenomics (PGx) testing for 35 medications commonly used in Australia.
-
UNSW’s new Dean
Wednesday | Apr 10 2024PROFESSOR Cheryl Jones has been appointed as the new Dean of Medicine & Health at the University of New South Wales (UNSW).
-
No clear link found
Wednesday | Apr 10 2024NEW research published in Nature Medicine shows that attention-deficit/hyperactivity disorder (ADHD) in children is unlikely to be directly caused by maternal diabetes during pregnancy.
-
ASA bites back
Wednesday | Apr 10 2024THE Australian Society of Anaesthetists (ASA) has hit back at ABC Four Corners' major investigation into the chronic pain industry, which found claims of fraud, waste and abuse.
-
Hypertension
Wednesday | Apr 10 2024A groundbreaking international review has found that dietary fibre is critical in managing high blood pressure or hypertension, which contributes to 19% of deaths around the world.
-
Dispensary Corner 10 Apr 24
Wednesday | Apr 10 2024NO one likes standing in long queues, but the situation is so dire at one particular pharmacy in the UK, that local government officials are in "urgent talks" to find a solution.
-
Probiotic Gut Support with Bioglan Medlab SB5B
Wednesday | Apr 10 2024SB 5B contains 5 billion CFU of Saccharomyces cerevisiae (Boulardii) (SB) which supports healthy immune and gut function.
-
Mag-Sup Powder – a better way to absorb magnesium
Wednesday | Apr 10 2024MAG-SUP powder is a high absorption magnesium supplement for use in magnesium deficiencies.
-
Starpharma launches new venture
Tuesday | Apr 9 2024AUSTRALIAN biopharmaceutical company, Starpharma, has partnered with life sciences investment firm Medicxi to launch a new UK-based company called Petalion Therapeutics Limited.